CME Group (NASDAQ:CME – Get Rating) had its target price decreased by Credit Suisse Group from $218.00 to $216.00 in a report issued on Wednesday morning, MarketBeat reports. Credit Suisse Group currently has a neutral rating on the financial services provider’s stock.
Other equities research analysts have also issued research reports about the company. Jefferies Financial Group initiated coverage on CME Group in a report on Tuesday, May 31st. They issued a buy rating and a $267.00 price objective on the stock. Morgan Stanley lowered their price objective on CME Group from $242.00 to $226.00 and set an equal weight rating on the stock in a report on Thursday, July 28th. UBS Group lowered their price objective on CME Group from $246.00 to $240.00 and set a buy rating on the stock in a report on Tuesday. Deutsche Bank Aktiengesellschaft lifted their price objective on CME Group from $210.00 to $213.00 and gave the company a hold rating in a report on Wednesday, July 13th. Finally, Oppenheimer raised CME Group from a market perform rating to an outperform rating and set a $223.00 price target on the stock in a research note on Wednesday, May 25th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of Hold and an average target price of $237.67.
CME Group Stock Performance
NASDAQ CME opened at $202.15 on Wednesday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group has a 52-week low of $185.79 and a 52-week high of $256.94. The business’s 50-day moving average price is $202.69 and its 200 day moving average price is $219.59. The firm has a market cap of $72.66 billion, a P/E ratio of 25.08, a P/E/G ratio of 3.22 and a beta of 0.40.
CME Group Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 27th. Investors of record on Friday, September 9th will be given a dividend of $1.00 per share. The ex-dividend date of this dividend is Thursday, September 8th. This represents a $4.00 annualized dividend and a dividend yield of 1.98%. CME Group’s dividend payout ratio is currently 49.63%.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the stock. Ascent Group LLC raised its holdings in CME Group by 7.2% in the 2nd quarter. Ascent Group LLC now owns 14,673 shares of the financial services provider’s stock valued at $2,927,000 after acquiring an additional 982 shares during the last quarter. M&T Bank Corp raised its holdings in CME Group by 0.7% in the 2nd quarter. M&T Bank Corp now owns 74,869 shares of the financial services provider’s stock valued at $14,953,000 after acquiring an additional 504 shares during the last quarter. Thornburg Investment Management Inc. raised its holdings in CME Group by 3.5% in the 2nd quarter. Thornburg Investment Management Inc. now owns 2,116,756 shares of the financial services provider’s stock valued at $433,300,000 after acquiring an additional 71,447 shares during the last quarter. Pinebridge Investments L.P. raised its holdings in CME Group by 128.0% in the 2nd quarter. Pinebridge Investments L.P. now owns 228 shares of the financial services provider’s stock valued at $47,000 after acquiring an additional 128 shares during the last quarter. Finally, Souders Financial Advisors raised its holdings in CME Group by 15.7% in the 2nd quarter. Souders Financial Advisors now owns 20,362 shares of the financial services provider’s stock valued at $4,168,000 after acquiring an additional 2,769 shares during the last quarter. 86.71% of the stock is currently owned by institutional investors and hedge funds.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.
- Get a free copy of the StockNews.com research report on CME Group (CME)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.